Collagen Diseases  >>  Palexia RP (tapentadol extended release)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Palexia RP (tapentadol extended release) / Assertio, J&J, Grunenthal, Collegium Pharma
NCT00745069: Efficacy and Safety of Tapentadol Extended Release Tablets in the Treatment of Moderate to Severe Pain in Subjects With Knee Osteoarthritis

Completed
2b
670
US
tapentadol HCl
Johnson & Johnson Pharmaceutical Research & Development, L.L.C., GrĂ¼nenthal GmbH
Osteoarthitis, Chronic Pain, Knee Pain
 
08/05
NCT01124604: An Efficacy and Safety Study for Tapentadol Extended Release (JNS024ER) in Chronic Pain Participants

Completed
2
91
Japan
Tapentadol Hydrochloride, Placebo
Janssen Pharmaceutical K.K.
Pain, Low Back Pain, Back Pain, Osteoarthritis, Knee
12/10
12/10

Download Options